Our “Connect the Dots” articles continue to provide investors with insight and clarity into the marijuana sector.
Our research and analysis has enabled our readers and subscribers the chance to capitalize on 4 companies whose stocks saw a combined gain of 2,363% in just a couple months. Our most recent articles identifying opportunities with Oxis International (OXIS) and Blue Line Protection Group (BLPG) have already resulted in 187% in gains and we believe this could be just the beginning.
Both OXIS and BLPG have recently seen significant increases in trading volume and share price proving that word is spreading and people are starting to take notice of what these companies are doing. OXIS has seen a 140% increase in share price since we issued our “Connect the Dots” in January 2015 and BLPG a 47% increase just one week following our “Connect the Dots” piece on March 16, 2015.
Game Changing News
The marijuana industry is all about catalysts. Always look for news events that could drastically boost a company’s growth or business plan progression. That is exactly why we are focusing on these two companies for long term growth and success.
Blue Line Protection Group
In 2016, 5 more states are gearing up to potentially legalize marijuana. Connecticut has already decriminalized marijuana as any person with a marijuana possession charge will have their record expunged. But Nevada is already set to vote on legalizing marijuana in the 2016 elections and California, Arizona, Maine, and Massachusetts look like they could be doing the same. If even just one of these states legalizes marijuana, we are looking at a potential game changing event for BLPG as this will open up a new potential market for the company to enter directly resulting in expansion and revenue growth.
Blue Line Protection is already receiving tons of media exposure as they have been featured on abc7 News, NY Daily News, BizJournals.com, Inc.com, Fortune.com, and CNBCprime.com. As the marijuana industry grows people are recognizing the strong need for intense security as well as new banking solutions and Blue Line offers both. They are already operating in many of the legal states with plans of expanding into every major market where marijuana is accepted. A state like California, Arizona, or Massachusetts legalizing marijuana would present an immense business opportunity for this company and could certainly be a game changing event for them.
What we like about BLPG is the fact that they can very quickly enter new markets. This should cause their growth rates to be higher in the early years of the marijuana industry than other marijuana related companies. They do not have to go through the vigorous and time consuming licensing application process that growers and other companies who directly touch the plant must do to operate in a new state. They simply set up shop, hire and train former military veterans and police officers, and begin selling their services, which are very high in demand. They are not bound to specific states. If marijuana is legal, this company will be there. And we like that.
Oxis International
The cannabis biotech space is heating up and very quickly becoming a main topic of discussion on Wall Street. Why? Because everyone sees the push for medical marijuana getting stronger and biotech juggernauts GW Pharmaceuticals (GWPH) and Insys Therapeutics (INSYS) continue to outperform the market while sporting market caps around $2 Billion.
Wall Street thinks it is much more likely for the government to approve the use of medical marijuana nationwide than it is to see a free-for-all for recreational marijuana use. It’s become quite obvious that a nationwide acceptance of medical marijuana must come first before we can even think about a nationwide acceptance for recreational use. And companies like GWPH and INSY are already way ahead of the curve and having tremendous success with drug trials featuring cannabinoid molecules. And their stock performance sure does reflect that.
GWPH is up an incredible 967% since 2013 and INSY is up 933% during that same time frame. But those companies are trading at $97 and $62 a share respectively. If you aren’t in them already you may have missed the bulk of the growth. So what company could be next to experience such development and progression? We think that company could be OXIS. And here’s why.
The management team that has come onboard to OXIS has a long history of success in the public biotech space. In fact, the CEO and many of the scientific board members and original investors of OXIS laid the groundwork in a company called Genesis Biopharma (GNBP) which later merged with Lion Biotechnologies and began trading under ticker symbol LBIO. When the new OXIS team first got involved with what is now LBIO, the market cap was less than $2 Million and the stock was trading for pennies a share. Now LBIO sports a market cap of nearly $390 Million and trades around $14 a share.
But what has us most excited is that we are starting to see the same business strategy deployed in OXIS as we saw in the early days of LBIO. The CEO continues to acquire industry leading data and drug patents that show tremendous promise in fighting multiple types of cancer. Capital raise for drug trials should be an easy task as the bankers from LBIO are surely foaming at the mouth to throw money at this management team again. And I’m sure it doesn’t hurt to have an FDA employee on your Scientific Advisory Board, which OXIS has, in addition to the world’s leading cannabinoid scientist and nation’s top biotech patent attorney with a long list of FDA experience. Just Google the members of this company’s advisory board and I guarantee you impressive will be an understatement.
Summary
When identifying opportunities in the marijuana sector we look for catalysts, things that can boost a company’s growth or business plan progression. We want to be exposed to the industry’s growth without taking on the added volatility and uncertainty from legislative decisions involving the actual plant itself. That is why we are focusing on two companies operating in the cannabis space with tremendous potential that do not actually touch the marijuana plant. However, they are positioned beautifully to grow in parallel with the overall industry, if not at a faster rate.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
